CliffBio
small molecule

CLOCORTOLONE PIVALATE

CLOCORTOLONE PIVALATE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLOCORTOLONE PIVALATE
Active ingredientCLOCORTOLONE PIVALATE
Strength0.1%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalApril 2020
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.